Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis-Reference-Cited by-同舟云学术

Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis

Published:2011-01 Issue:1 Volume:59 Page:135-141
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Sun Maxine,Thuret Rodolphe,Abdollah Firas,Lughezzani Giovanni,Schmitges Jan,Tian Zhe,Shariat Shahrokh F.,Montorsi Francesco,Patard Jean-Jacques,Perrotte Paul,Karakiewicz Pierre I.

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Rising incidence of small renal masses: a need to reassess treatment effect;Hollingsworth;J Natl Cancer Inst,2006

3. Global increases in kidney cancer incidence, 1973–1992;Mathew;Eur J Cancer Prev,2002

4. Contemporary epidemiology of renal cell cancer;Chow;Cancer J,2008

5. Rising incidence of renal cell cancer in the United States;Chow;JAMA,1999

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of clear cell renal cell carcinoma ≤ 4cm: visual assessment of ultrasound characteristics versus ultrasonographic radiomics analysis;Frontiers in Oncology;2024-07-23

2. Disease Burden and Changing Trends of Kidney Cancer between 1990 and 2021: A Comparative Analysis of China and the World;2024-07-16

3. Decomposing difference in the kidney cancer burden measures between 1990 and 2019 based on the global burden of disease study;Scientific Reports;2024-05-06

4. To characterize small renal cell carcinoma using diffusion relaxation correlation spectroscopic imaging and apparent diffusion coefficient based histogram analysis: a preliminary study;La radiologia medica;2024-04-25

5. SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma;Clinical Genitourinary Cancer;2024-04